Home › NEOGEN › Filing
🔔 Get instant alerts when NEOGEN files quarterly results on BSE Start free trial →

Outcome of Board Meeting

Filed: 31 Oct 2026, 19:53 IST Exchange: NSE Category: Financial Results — Audited Results
Q2FY27 results (unaudited): Standalone: Revenue 28.8bn +39% y-y (20.7bn) PAT 2.11bn +127% y-y (0.93bn) Half year FY27 results (unaudited): Standalone: Revenue 54.0bn +38% y-y (39.1bn) PAT 4.06bn +73% y-y (2.36bn) FY26 results (audited): Standalone: Revenue 85.5bn +20% y-y (71.3bn) EBITDA 6.31bn +6% y-y (5.95bn) EBITDA margin 7.4% (8.3%) -90 bps y-y PAT 4.70bn +7% y-y (4.39bn) Consolidated: Revenue 86.2bn +20% y-y (71.0bn) EBITDA 8.27bn +4% y-y (7.95bn) EBITDA margin 9.6% (11.2%) -160 bps y-y PAT 2.88bn -8% y-y (3.13bn) Dividend: None declared Commentary: The company completed a QIP raising 60bn gross proceeds in Q2FY27; proceeds to be used for debt repayment, working capital and general corporate purposes. The company is recovering insurance claims related to a March 2025 fire incident with net claim receivable of 17.2bn as of September 30, 2026, and an additional 15.2bn approved post quarter. No deviation in QIP fund usage reported.
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 NEOGEN — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
⚡
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add NEOGEN to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Neogen Chemicals Limited

Important. The summary above is generated automatically from Neogen Chemicals Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.